Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems

被引：0
作者：
Efentakis M. [1 ]
Koutlis A. [1 ]
Vlachou M. [1 ]
机构：
[1] School of Pharmacy, Department of Pharmaceutical Technology, University of Athens, 157 71 Athens, Panepistimiopolis, Zografou
来源：
AAPS PharmSciTech | / 1卷 / 4期
关键词：
Carbopol; Controlled release; Furosemide; Minitablets; Multiple-unit; Single-unit; Sodium alginate;
D O I：
10.1208/pt010434
中图分类号：
学科分类号：
摘要：
This study compared the release behavior of single-unit (tablets, capsules) and multiple-unit (minitablets in capsules) controlled-release systems of furosemide. The swelling and erosion behaviors of these systems, which contained the swellable hydrophilic polymers sodium alginate (high viscosity) and Carbopol 974P, were compared. Swelling and erosion experiments showed a high degree of swelling and limited erosion for the Carbopol preparations, whereas less swelling but greater erosion was observed for the sodium alginate preparations. The sodium alginate preparations were eroded in 6 hours, while Carbopol preparations exhibited limited erosion within this period of time. These results appear to be attributed to the physicochemical characteristics of the polymers used in this study. Polymer characteristics greatly influenced the release of furosemide (model drug) from the formulations prepared and tested. Sodium alginate had a less pronounced sustained release effect compared with Carbopol (ie, in 8 hours all 3 sodium alginate dosage forms displayed complete release of furosemide, while only 30% of the drug was released from Carbopol dosage forms). Finally, all 3 Carbopol dosage forms (single- and multiple-unit) displayed similar release behavior while sodium alginate dosage forms displayed a different and more distinctive behavior. Minitablets and tablets showed a greater sustained release effect compared with capsules. Evaluation of the release data indicates that the release mechanism for sodium alginate formulations may be attributed to erosion/dissolution, while for Carbopol it may be attributed mainly to polymer relaxation and diffusion of the drug from the polymer surface.
引用
收藏
页数：9
相关论文
共 22 条
  • [1] Follonier N., Doelker E., Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms, STP Pharma. Sciences, 2, pp. 141-155, (1992)
  • [2] Vial-Bernasconi A.C., Doelker E., Buri P., Prolonged release capsules: Divided and monolithic forms, STP Pharma. Sciences, 4, pp. 397-409, (1988)
  • [3] Fan L.T., Singh S.K., Introduction, Controlled Release-A Quantitative Treatment, pp. 4-5, (1989)
  • [4] Fan L.T., Singh S.K., Diffusion-controlled release, Controlled Release-A Quantitative Treatment, pp. 61-79, (1989)
  • [5] Fan L.T., Singh S.K., Introduction, Controlled Release-A Quantitative Treatment, 3, (1989)
  • [6] Ojantakanen S., Effect of viscosity grade of polymer additive and compression force on release of ibuprofen from hard gelatin capsules, Acta. Pharm. Fenn., 101, pp. 119-126, (1992)
  • [7] Efentakis M., Vlachou M., Evaluation of high molecular weight poly(oxyethylene) (polyox) polymer: Studies of flow properties and release rates of furosemide and captopril from controlled release hard gelatin capsules, Pharm. Dev. Technol., 5, pp. 339-346, (2000)
  • [8] Digenis G.A., The in vivo behavior of multiparticulate versus single unit dosage formulations, Multipaticulate Oral Drug Delivery, pp. 333-355, (1994)
  • [9] Celik M., Compaction of multiparticulate oral dosage forms, Multipaticulate Oral Drug Delivery, pp. 181-215, (1994)
  • [10] Coupe A.J., Davis S.S., Wilding I.R., Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects, Pharm. Res., 8, pp. 360-364, (1991)
123